Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of oral factor Xa inhibitors versus vitamin-K antagonists in the early phase after acute ischemic stroke or TIA in the real-world setting: The PRODAST study.
Diener HC, Grosse GM, Hüsing A, Stang A, Kuklik N, Brinkmann M, Maurer GD, Soda H, Pohlmann C, Hilker-Roggendorf R, Popovic N, Kraft P, Mackert BM, Eschenfelder CC, Weimar C. Diener HC, et al. Among authors: hilker roggendorf r. Eur Stroke J. 2024 Apr 3:23969873241242239. doi: 10.1177/23969873241242239. Online ahead of print. Eur Stroke J. 2024. PMID: 38567789 Free article.
COVID-19 Vaccine-Associated Cerebral Venous Thrombosis in Germany.
Schulz JB, Berlit P, Diener HC, Gerloff C, Greinacher A, Klein C, Petzold GC, Piccininni M, Poli S, Röhrig R, Steinmetz H, Thiele T, Kurth T; German Society of Neurology SARS-CoV-2 Vaccination Study Group. Schulz JB, et al. Ann Neurol. 2021 Oct;90(4):627-639. doi: 10.1002/ana.26172. Epub 2021 Aug 23. Ann Neurol. 2021. PMID: 34288044 Free PMC article.
Role of dopamine agonists in Parkinson's disease therapy.
Woitalla D, Buhmann C, Hilker-Roggendorf R, Höglinger G, Koschel J, Müller T, Weise D. Woitalla D, et al. Among authors: hilker roggendorf r. J Neural Transm (Vienna). 2023 Jun;130(6):863-873. doi: 10.1007/s00702-023-02647-0. Epub 2023 May 11. J Neural Transm (Vienna). 2023. PMID: 37165120 Review.
Correction to: Role of dopamine agonists in Parkinson's disease therapy.
Woitalla D, Buhmann C, Hilker-Roggendorf R, Höglinger G, Koschel J, Müller T, Weise D. Woitalla D, et al. Among authors: hilker roggendorf r. J Neural Transm (Vienna). 2023 Sep 13. doi: 10.1007/s00702-023-02695-6. Online ahead of print. J Neural Transm (Vienna). 2023. PMID: 37702775 No abstract available.
Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessments.
Ophey A, Wolfsgruber S, Roeske S, Polcher A, Spottke A, Frölich L, Hüll M, Jessen F, Kornhuber J, Maier W, Peters O, Ramirez A, Wiltfang J, Liepelt-Scarfone I, Becker S, Berg D, Schulz JB, Reetz K, Wojtala J, Kassubek J, Storch A, Balzer-Geldsetzer M, Hilker-Roggendorf R, Witt K, Mollenhauer B, Trenkwalder C, Wittchen HU, Riedel O, Dodel R, Wagner M, Kalbe E. Ophey A, et al. Among authors: hilker roggendorf r. Alzheimers Dement (Amst). 2021 Sep 14;13(1):e12223. doi: 10.1002/dad2.12223. eCollection 2021. Alzheimers Dement (Amst). 2021. PMID: 34541284 Free PMC article.
Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in "cognitive status" converters?
Gorges M, Kunz MS, Müller HP, Liepelt-Scarfone I, Storch A, Dodel R, Hilker-Roggendorf R; LANDSCAPE Consortium; Berg D, Kalbe E, Braak H, Del Tredici K, Baudrexel S, Huppertz HJ, Kassubek J. Gorges M, et al. Hum Brain Mapp. 2020 Apr 15;41(6):1416-1434. doi: 10.1002/hbm.24884. Epub 2019 Dec 2. Hum Brain Mapp. 2020. PMID: 31789477 Free PMC article.
Structural brain signature of cognitive decline in Parkinson's disease: DTI-based evidence from the LANDSCAPE study.
Gorges M, Müller HP, Liepelt-Scarfone I, Storch A, Dodel R; LANDSCAPE Consortium; Hilker-Roggendorf R, Berg D, Kunz MS, Kalbe E, Baudrexel S, Kassubek J. Gorges M, et al. Ther Adv Neurol Disord. 2019 May 16;12:1756286419843447. doi: 10.1177/1756286419843447. eCollection 2019. Ther Adv Neurol Disord. 2019. PMID: 31205489 Free PMC article.
Comparative analysis of machine learning algorithms for multi-syndrome classification of neurodegenerative syndromes.
Lampe L, Niehaus S, Huppertz HJ, Merola A, Reinelt J, Mueller K, Anderl-Straub S, Fassbender K, Fliessbach K, Jahn H, Kornhuber J, Lauer M, Prudlo J, Schneider A, Synofzik M, Danek A, Diehl-Schmid J, Otto M; FTLD-Consortium Germany; Villringer A, Egger K, Hattingen E, Hilker-Roggendorf R, Schnitzler A, Südmeyer M, Oertel W; German Atypical Parkinson Consortium Study Group; Kassubek J, Höglinger G, Schroeter ML. Lampe L, et al. Among authors: hilker roggendorf r. Alzheimers Res Ther. 2022 May 3;14(1):62. doi: 10.1186/s13195-022-00983-z. Alzheimers Res Ther. 2022. PMID: 35505442 Free PMC article.
Long-Term Cognitive Decline Related to the Motor Phenotype in Parkinson's Disease.
Michels J, van der Wurp H, Kalbe E, Rehberg S, Storch A, Linse K, Schneider C, Gräber S, Berg D, Dams J, Balzer-Geldsetzer M, Hilker-Roggendorf R, Oberschmidt C, Baudrexel S, Witt K, Schmidt N, Deuschl G, Mollenhauer B, Trenkwalder C, Liepelt-Scarfone I, Spottke A, Roeske S, Wüllner U, Wittchen HU, Riedel O, Kassubek J, Dodel R, Schulz JB, Costa AS, Reetz K. Michels J, et al. Among authors: hilker roggendorf r. J Parkinsons Dis. 2022;12(3):905-916. doi: 10.3233/JPD-212787. J Parkinsons Dis. 2022. PMID: 35068416
20 results